AMED vs LHC Comparison: AI Score, Valuation, Performance and Upside
Compare Amedisys and LHC Group by Medicare-certified home health visit volume, hospice admission growth, PDGM reimbursement impact, and how the consolidation of the home health sector through M&A reshapes competitive positioning for the two largest independent operators.
Use this Amedisys vs LHC Group comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.
AMED and LHC are closely matched — they split the tracked metrics evenly.
| Metric | AMED | LHC |
|---|---|---|
| AI score | N/A | N/A |
| AI rank | N/A | N/A |
| Latest close | N/A | N/A |
| 1M return | N/A | N/A |
| 6M return | N/A | N/A |
| 1Y return | N/A | N/A |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | AMED | LHC |
|---|
Hypothetical — past performance does not guarantee future results.
| Metric | AMED | LHC |
|---|---|---|
| Market cap | N/A | N/A |
| Trailing P/E | N/A | N/A |
| Forward P/E | N/A | N/A |
| Price/Sales | 1.41 | N/A |
| EV/Revenue | N/A | N/A |
| Analyst target | N/A | N/A |
| Target upside | N/A | N/A |
| Metric | AMED | LHC |
|---|---|---|
| Revenue growth | N/A | N/A |
| Earnings growth | N/A | N/A |
| EPS growth | N/A | N/A |
| FCF margin | N/A | N/A |
| Operating margin | N/A | N/A |
| Profit margin | N/A | N/A |
| ROIC proxy | N/A | N/A |
| Return on equity | N/A | N/A |
| Dividend yield | N/A | N/A |
| Beta | 0.40 | 0.05 |
| Debt/equity | N/A | N/A |
| Current ratio | N/A | N/A |
| Quick ratio | N/A | N/A |
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | AMED | LHC |
|---|---|---|---|
| 1Y | Growth | N/A | N/A |
| CAGR | N/A | N/A | |
| Sharpe ratio | N/A | N/A | |
| Max drawdown | N/A | N/A | |
| Max daily drop | N/A | N/A | |
| Max wkly drop | N/A | N/A | |
| 5Y | Growth | N/A | N/A |
| CAGR | N/A | N/A | |
| Sharpe ratio | N/A | N/A | |
| Max drawdown | N/A | N/A | |
| Max daily drop | N/A | N/A | |
| Max wkly drop | N/A | N/A | |
| 10Y | Growth | N/A | N/A |
| CAGR | N/A | N/A | |
| Sharpe ratio | N/A | N/A | |
| Max drawdown | N/A | N/A | |
| Max daily drop | N/A | N/A | |
| Max wkly drop | N/A | N/A |
| Category | AMED | LHC |
|---|---|---|
| Company | AMED | LHC |
| Sector | N/A | N/A |
| Industry | N/A | N/A |
| Core business | N/A | N/A |
| Investor focus | N/A | N/A |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.